Skip to Main Content

Author Details

Mohan Somasundaran
University of Massachusetts Chan Medical School
1985
62
27
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36893269Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.Proc Natl Acad Sci U S A2023
35045267Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.J Virol2022
37274537Anti-SARS-CoV-2 Activity of Adamantanes In Vitro and in Animal Models of Infection.COVID2022
35891350A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.Viruses2022
35290796Quantitative structural analysis of influenza virus by cryo-electron tomography and convolutional neural networks.Structure2022
34293929SARS-CoV-2 Initiates Programmed Cell Death in Platelets.Circ Res2021
33619959Inhibiting HTLV-1 Protease: A Viable Antiviral Target.ACS Chem Biol2021
33495478Unique structural solution from a V<sub>H</sub>3-30 antibody targeting the hemagglutinin stem of influenza A viruses.Nat Commun2021
30381484Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.J Virol2019
29093087Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection.J Virol2018
29687407Ultradeep single-molecule real-time sequencing of HIV envelope reveals complete compartmentalization of highly macrophage-tropic R5 proviral variants in brain and CXCR4-using variants in immune and peripheral tissues.J Neurovirol2018
29760455Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.Sci Rep2018
29118121HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.J Virol2018
28452355Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.Nat Commun2017
27104621Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants.PLoS One2016
27733645High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.J Virol2016
25693029Viremic relapse after HIV-1 remission in a perinatally infected child.N Engl J Med2015
26573574Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission.Retrovirology2015
26416268A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection.J Immunol2015
25914058The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.Structure2015
24429365Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.J Virol2014
23685212Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.Structure2013
22181350First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.ACS Chem Biol2012
23151449Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates.Hum Vaccin Immunother2012
22821539Mass spectrometry tools for analysis of intermolecular interactions.Methods Mol Biol2012
21843318Genotypic and functional properties of early infant HIV-1 envelopes.Retrovirology2011
20152150Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.Structure2010
20886079Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.PLoS One2010
20578491Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART).Southeast Asian J Trop Med Public Health2010
19503790Low-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR.PLoS One2009
18177249Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.J Infect Dis2008
18614660Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C.J Clin Microbiol2008
17492595Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.J Infect Dis2007
17598142Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.Proteins2007
15655773Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.J Infect Dis2005
16049331Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus.Am J Pathol2005
15989462Nuclear localization of HIV type 1 Vif isolated from a long-term asymptomatic individual and potential role in virus attenuation.AIDS Res Hum Retroviruses2005
15452268Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.J Virol2004
12594286Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.J Immunol2003
14647384Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.Nature2003
12036487Enhanced culture method for detection of replication-competent virus in peripheral blood mononuclear cells of HIV type 1-infected individuals.AIDS Res Hum Retroviruses2002
12093916Evidence for a cytopathogenicity determinant in HIV-1 Vpr.Proc Natl Acad Sci U S A2002
10659052Attenuation of human immunodeficiency virus type 1 cytopathic effects by replacing a 424-bp region of envelope from a noncytopathic biological clone.AIDS Res Hum Retroviruses2000
10558933Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort.J Infect Dis1999
9333151In vitro characterization of adult primary human immunodeficiency virus type 1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels of viral replication.J Infect Dis1997
9207357Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo.J Infect Dis1997
9232625Detection and differentiation of Epstein-Barr virus strains by in situ polymerase chain reaction.Mol Cell Probes1997
8947293In vitro characterization of HIV type 1 biological clones from asymptomatic and symptomatic pediatric patients.AIDS Res Hum Retroviruses1996
7658067Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children.J Infect Dis1995
7888220Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.AIDS Res Hum Retroviruses1994
  • 1 - 50 of 62

Recommended Authors

Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 0
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 2
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 1
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 3
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 1
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 1
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 2
University of Utah
Career Start Year 1991
Number of shared co-authors 2
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 2
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 0
University of California san francisco
Career Start Year 1988
Number of shared co-authors 6
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 3
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 2
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year 1978
Number of shared co-authors 2
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 2
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 0
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 0
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 2
Center for Family Health Research Zambia
Career Start Year 1971
Number of shared co-authors 1
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 2

Collaborators

University of Massachusetts Chan Medical School
Co-authored papers 13
University of Massachusetts Medical School
Co-authored papers 6
Frederick National Laboratory for Cancer Research
Co-authored papers 4
Co-authored papers 3
University of Texas Health San Antonio
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 3
University of Minnesota
Co-authored papers 2
Co-authored papers 2
Department of Cancer Research Institute, University of South Australia
Co-authored papers 2
University of Massachusetts Chan Medical School
Co-authored papers 2
Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of Massachusetts Chan Medical School
Co-authored papers 1
University of Minnesota
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
Institute for Therapeutics Discovery and Development, University of Minnesota
Co-authored papers 1
Co-authored papers 1
Graduate School of Medicine, Kyoto University
Co-authored papers 1
University of Massachusetts Chan Medical School
Co-authored papers 1
Co-authored papers 1
University of Minnesota
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
University of Minnesota
Co-authored papers 1
Merck & Co. Inc.
Co-authored papers 1
Fred Hutchinson Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1